Product Information
CHILD'S MAPAP 160 MG TAB CHEW is a generic product labeled by Major Pharmaceuticals, priced at $0.1164 per EA under NDC 00904664524. Its NADAC has been published 463 times since Nov 22, 2017.
Strength
160 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904664524
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
2/25/2005
Price Statistics
The NADAC for CHILD'S MAPAP 160 MG TAB CHEW has been published 463 times since Nov 22, 2017, and over the history we have for it it has risen 62.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1164 per EA |
|---|---|
| All-time high | $0.1249 (Jan 11, 2023) |
| All-time low | $0.0718 (Nov 22, 2017) |
| 52-week high | $0.1211 |
| 52-week low | $0.1146 |
| Median price | $0.1111 |
| Average price | $0.1085 |
| Largest weekly change | +36.4% (Aug 19, 2020) |
| Weeks tracked | 463 |
| Tracking since | Nov 22, 2017 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHILD'S MAPAP 160 MG TAB CHEW?
The current National Average Drug Acquisition Cost (NADAC) for CHILD'S MAPAP 160 MG TAB CHEW, manufactured by Major Pharmaceuticals, is $0.1164 per EA (NDC 00904664524), effective Sep 30, 2026.
How has the price of CHILD'S MAPAP 160 MG TAB CHEW changed over time?
Over the history we have for it, the NADAC for CHILD'S MAPAP 160 MG TAB CHEW has risen 62.1%. It has been tracked across 463 weekly CMS publications since Nov 22, 2017.
What are the highest and lowest recorded NADAC prices for CHILD'S MAPAP 160 MG TAB CHEW?
Since Nov 22, 2017, the NADAC for CHILD'S MAPAP 160 MG TAB CHEW has ranged from a low of $0.0718 (Nov 22, 2017) to a high of $0.1249 (Jan 11, 2023), with a median of $0.1111 per EA.
Are there cheaper alternatives to CHILD'S MAPAP 160 MG TAB CHEW?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CHILD'S MAPAP 160 MG TAB CHEW in a comparable dosage form, but none are currently priced below it.
Who manufactures CHILD'S MAPAP 160 MG TAB CHEW?
CHILD'S MAPAP 160 MG TAB CHEW (NDC 00904664524) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.